Niigata Univ., Eisai Team Up to Develop Pancreatic Cancer Drug Using Highly Absorbed Peptide

May 7, 2019
Niigata University will collaborate with Eisai to discover and develop a treatment for pancreatic cancer by using a highly absorbed peptide developed by the university, it said on April 25. A research team led by Eisaku Kondo, professor at the...read more